PATENT CLAIM ANALYSIS

Application Number: 16193814
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "211000"]

Abstract:
The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.

Claim (Index 20):
A method of activating a mu-opioid receptor or delta-opioid receptor comprising contacting the mu-opioid receptor or delta-opioid receptor with the compound of any one of  claims 1 - 18 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.11765
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15125557', '15850123', '15401791', '12218754', '15541018']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7963222926357907
- 35 USC 102 Novelty (BERT): 0.6017877155957174
- Combined Prediction Score: 0.7768688349317834
- Mean Citation Score: 388.969614
- Max Citation Score: 556.03394
- Similarity Product: 464.09746200746537

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test